Aurinia Pharmaceuticals Inc. Annual Share-based Payment Arrangement, Expense in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Aurinia Pharmaceuticals Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2018 to 2023.
  • Aurinia Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $8.33M, a 29.5% decline year-over-year.
  • Aurinia Pharmaceuticals Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $34.4M, a 14.9% decline year-over-year.
  • Aurinia Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45.3M, a 40.3% increase from 2022.
  • Aurinia Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2022 was $32.3M, a 3.38% increase from 2021.
  • Aurinia Pharmaceuticals Inc. annual Share-based Payment Arrangement, Expense for 2021 was $31.2M, a 79% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $45.3M +$13M +40.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-15
2022 $32.3M +$1.06M +3.38% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-15
2021 $31.2M +$13.8M +79% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-15
2020 $17.5M +$10M +135% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $7.41M +$554K +8.08% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $6.86M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.